Business · Companies · 14 hrs ago
India extends medical device manufacturing incentive scheme to 2035-36
India has extended its medical device manufacturing incentive scheme to 2035-36 and invited companies to apply for support.
The programme offers financial incentives to manufacturers in India, with about ₹2,700 crore available under the scheme.
Revised rules remove the minimum sales threshold for claiming incentives and reduce the minimum investment requirement.
The government says the changes are intended to make the scheme easier for investors to use and encourage more domestic production.
Since the scheme began in 2021-22, it has supported production of more than 60 types of high-end devices, worth over ₹16,000 crore.
Companies can apply through an online portal due to launch within 10 days, including for support to make components, implants and medical equipment.
India has extended its medical device production incentive scheme until 2035-36 and invited fresh applications.
The scheme has an outlay of about Rs 2,700 crore, according to the Department of Pharmaceuticals.
Revised guidelines remove the minimum sales threshold for claiming incentives and reduce the minimum investment requirement.
Applicants will be able to apply online through a portal expected to launch within 10 days.
The scheme has supported production worth more than Rs 16,000 crore and domestic manufacturing of over 60 high-end devices and components.
- Who
- The Department of Pharmaceuticals has invited applications from medical device manufacturers.
- What
- India extended the Production Linked Incentive scheme for medical devices to 2035-36 and invited fresh applications.
- When
- The announcement was reported on November 10 and 11, 2026.
- Where
- India.
- Why
- The scheme aims to promote domestic manufacturing, attract investment and strengthen the medical technology sector.
This story does not have two clearly opposing sides.
The scheme was launched; ET HealthWorld gives 2020-21, while Times of India gives 2021-22.
The government announced the extension to 2035-36 and invited fresh applications, according to Times of India.
The online application portal is expected to become operational.
- Scheme outlay
- About Rs 2,700 crore
- Extended until
- 2035-36
- Minimum sales threshold
- Removed for claiming incentives
- Production under scheme
- More than Rs 16,000 crore
- Devices and components
- Over 60 high-end products
- Application portal
- Expected to launch within 10 days
3 sources
What people are saying
PLI-MD 2.0 aims to fulfil the vision of Atmanirbhar Bharat and Make in India, develop indigenous supply chains, attract investment, generate employment, improve quality of Made in India devices, reduce price of medical devices, and enhance India's global competitiveness in high-end medical technologies.
The Association of Indian Medical Device Industry (AiMeD) warmly welcomes the Government’s continued commitment to strengthening domestic medical device manufacturing through the Production Linked Incentive (PLI) Scheme(V2.0), which aims to boost local manufacturing and attract investments into India’s medical technology sector.
A supportive framework comprising tariff rationalisation, a dedicated medical devices law, procurement preference for genuine manufacturers, and balanced trade margin policies can transform India from a large consumer market into a global MedTech manufacturing powerhouse.
The enhanced focus on critical component manufacturing is particularly significant, as components are the backbone of the MedTech industry.